Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Los Angeles, California
- Most recent report
- 10-Q, filed Nov 9, 2026
- Incorporated
- Delaware
- Filings on record
- 1,001+ filings
- On EDGAR
- CIK 1401667
- Fiscal year ends
- December
- Filer status
- Accelerated filer, Smaller reporting company
Financials 8 of 58
News 8 of 194
Prospectuses and Registrations 8 of 25
- S-8 Registration statement for an employee plan Aug 27, 2024
- 424B3 Prospectus supplement for an offering Aug 2, 2022
- S-3 Shelf registration statement Jul 25, 2022
- 424B5 Prospectus supplement for an offering Nov 4, 2021
- S-8 Registration statement for an employee plan Sep 16, 2021
- S-3 Shelf registration statement Jul 2, 2021
- S-8 Registration statement for an employee plan Feb 28, 2020
- S-8 Registration statement for an employee plan Jul 19, 2017
Proxies 8 of 42
- DEFA14A Extra proxy material Apr 28, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2026
- PRE 14A Preliminary proxy statement Apr 7, 2026
- DEFA14A Extra proxy material Apr 28, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2025
- DEFA14A Extra proxy material Apr 26, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2024
- DEFA14A Extra proxy material Apr 28, 2023
Ownership 8 of 622
- SCHEDULE 13D/A Large holder reported an active stake, amended Oct 6, 2026
- 4 Insider reported a trade Sep 16, 2026
- 4 Insider reported a trade Sep 16, 2026
- 144 Notice of a proposed sale of restricted stock Sep 14, 2026
- 144 Notice of a proposed sale of restricted stock Sep 14, 2026
- 4 Insider reported a trade Jul 8, 2026
- 4 Insider reported a trade Jul 8, 2026
- 4 Insider reported a trade Jul 8, 2026
Other 8 of 60
- ARS Annual report sent to shareholders Apr 28, 2026
- ARS Annual report sent to shareholders Apr 28, 2025
- ARS Annual report sent to shareholders Apr 26, 2024
- ARS Annual report sent to shareholders Apr 28, 2023
- EFFECT Notice that a registration became effective Aug 1, 2022
- CORRESP Reply to SEC staff Jul 28, 2022
- UPLOAD Comment letter from SEC staff Jul 27, 2022
- EFFECT Notice that a registration became effective Jul 13, 2021
Everything here comes from Puma Biotechnology, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.